These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 30899298)

  • 1. Vitreous concentrations of vascular endothelial growth factor as a potential biomarker for postoperative complications following pars plana vitrectomy.
    Nisic F; Jovanovic N; Mavija M; Alimanovic-Halilovic E; Nisic A; Lepara O; Cemerlic A
    Arch Med Sci; 2019 Mar; 15(2):449-456. PubMed ID: 30899298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Intravitreal Conbercept Injection on Complications of Pars Plana Vitrectomy in Patients with Proliferative Diabetic Retinopathy.
    Ding Y; Su N; Luan J; Ni Y; Sun Z
    J Pers Med; 2023 Mar; 13(4):. PubMed ID: 37108958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Efficacy of Preoperative and Intraoperative Intravitreal Ranibizumab as Adjuvant Therapy of Ahmed Glaucoma Valve Implantation Combined with Vitrectomy in the Management of Neovascular Glaucoma with Diabetic Vitreous Hemorrhage.
    Gao S; Lin Z; Zhong Y; Shen X
    J Pers Med; 2023 Dec; 14(1):. PubMed ID: 38248719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraocular VEGF level as a risk factor for postoperative complications after vitrectomy for proliferative diabetic retinopathy.
    Wakabayashi Y; Usui Y; Okunuki Y; Ueda S; Kimura K; Muramatsu D; Kezuka T; Goto H
    Invest Ophthalmol Vis Sci; 2012 Sep; 53(10):6403-10. PubMed ID: 22899753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ranibizumab Plus Combined Surgery for Treatment of Neovascular Glaucoma with Vitreous Hemorrhage.
    Li XJ; Yang XP; Li QM; Wang YY; Lyu XB
    Chin Med J (Engl); 2015 Aug; 128(15):2078-83. PubMed ID: 26228222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Anti-Vascular Endothelial Growth Factor Drugs Before and After Pars Plana Vitrectomy in Patients with Polypoidal Choroidal Vasculopathy and Vitreous Hemorrhage.
    Chen L; Qu L; Gui Q; Wang S; Mao J; Fu X; Li W; Wang Y; Yi Q
    J Ocul Pharmacol Ther; 2021 Dec; 37(10):591-596. PubMed ID: 34678098
    [No Abstract]   [Full Text] [Related]  

  • 7. Endodiathermy plus photocoagulation as treatment of sclerotomy site vascularization secondary to pars plana vitrectomy for proliferative diabetic retinopathy.
    Nadal J; Carreras E; Canut MI
    Retina; 2012 Jul; 32(7):1310-5. PubMed ID: 22466471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ahmed Valves vs Trabeculectomy Combined with Pans Plana Vitrectomy for Neovascular Glaucoma with Vitreous Hemorrhage.
    Wang MH; Li QM; Dong HT; Dong SQ; Li Y; Zheng CY
    Eur J Ophthalmol; 2017 Nov; 27(6):774-780. PubMed ID: 28430329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pars plana vitrectomy and panretinal photocoagulation combined with trabeculectomy for successful treatment of neovascular glaucoma.
    Kiuchi Y; Nakae K; Saito Y; Ito S; Ito N
    Graefes Arch Clin Exp Ophthalmol; 2006 Dec; 244(12):1627-32. PubMed ID: 16639623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitreous and plasma concentrations of apelin and vascular endothelial growth factor after intravitreal bevacizumab in eyes with proliferative diabetic retinopathy.
    Qian J; Lu Q; Tao Y; Jiang YR
    Retina; 2011 Jan; 31(1):161-8. PubMed ID: 20890241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal timing of preoperative intravitreal anti-VEGF injection for proliferative diabetic retinopathy patients.
    Xu Y; Xie C; Fang Y; Yu Y; Qiu C
    Int J Ophthalmol; 2022; 15(10):1619-1626. PubMed ID: 36262859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ziv-aflibercept versus bevacizumab administration prior to diabetic vitrectomy: a randomised and controlled trial.
    Aleman I; Castillo Velazquez J; Rush SW; Rush RB
    Br J Ophthalmol; 2019 Dec; 103(12):1740-1746. PubMed ID: 30705040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy and safety of intravitreal injection of Ranibizumab as pre-treatment for vitrectomy in proliferative diabetic retinopathy with vitreous hemorrhage.
    Li S; Yang Y; Zou J; Zeng J; Ding C
    BMC Ophthalmol; 2022 Feb; 22(1):63. PubMed ID: 35139812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of 25-gauge pars plana vitrectomy in the surgical management of proliferative diabetic retinopathy.
    Schoenberger SD; Miller DM; Riemann CD; Foster RE; Sisk RA; Hutchins RK; Petersen MR
    Ophthalmic Surg Lasers Imaging; 2011; 42(6):474-80. PubMed ID: 21902167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microincision vitrectomy surgery and intravitreal bevacizumab as a surgical adjunct to treat diabetic traction retinal detachment.
    Oshima Y; Shima C; Wakabayashi T; Kusaka S; Shiraga F; Ohji M; Tano Y
    Ophthalmology; 2009 May; 116(5):927-38. PubMed ID: 19269033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Bevacizumab Injection before Vitrectomy on Intravitreal Hemorrhage in Pseudophakic Patients with Proliferative Diabetic Retinopathy.
    Demir M; Oba E; Can E; Kara O; Cinar S
    Ophthalmol Eye Dis; 2013; 5():11-5. PubMed ID: 23926440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors Affecting the Results of Ahmed Glaucoma Valve Implantation in Diabetic Neovascular Glaucoma With or Without Previous Pars Plana Vitrectomy.
    Tekcan H; Imamoglu S; Ozturk Y
    Beyoglu Eye J; 2024; 9(2):76-85. PubMed ID: 38854899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravitreal long-acting gas in the prevention of early postoperative vitreous hemorrhage in diabetic vitrectomy.
    Yang CM; Yeh PT; Yang CH
    Ophthalmology; 2007 Apr; 114(4):710-5. PubMed ID: 17275908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravitreal ranibizumab versus vitrectomy for recurrent vitreous haemorrhage after pars plana vitrectomy for proliferative diabetic retinopathy: a prospective study.
    Chatziralli I; Dimitriou E; Theodossiadis G; Bourouki E; Bagli E; Kitsos G; Theodossiadis P
    Int Ophthalmol; 2020 Apr; 40(4):841-847. PubMed ID: 31788713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Six-month visual outcome after pars plana vitrectomy in proliferative diabetic retinopathy with or without a single preoperative injection of intravitreal bevacizumab.
    Gupta A; Bansal R; Gupta V; Dogra MR
    Int Ophthalmol; 2012 Apr; 32(2):135-44. PubMed ID: 22450558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.